Shannon L. Devers's most recent trade in Ionis Pharmaceuticals Inc was a trade of 3,977 Common Stock done at an average price of $81.3 . Disclosure was reported to the exchange on Jan. 22, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Sale of securities on an exchange or to another person at price $ 81.34 per share. | 22 Jan 2026 | 3,977 | 22,541 (0%) | 0% | 81.3 | 323,490 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2026 | 25,800 | 47,800 | - | - | Performance Restricted Stock Units | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2026 | 17,377 | 43,029 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2026 | 17,377 | 34,871 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2026 | 9,675 | 52,704 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Sale of securities on an exchange or to another person at price $ 75.95 per share. | 15 Jan 2026 | 8,353 | 26,518 (0%) | 0% | 75.9 | 634,410 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.78 per share. | 07 Jan 2026 | 25,545 | 43,039 (0%) | 0% | 56.8 | 1,450,445 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 25,545 | 2,971 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Sale of securities on an exchange or to another person at price $ 85.36 per share. | 07 Jan 2026 | 25,545 | 17,494 (0%) | 0% | 85.4 | 2,180,521 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 9,264 | 9,262 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Sale of securities on an exchange or to another person at price $ 84.62 per share. | 07 Jan 2026 | 9,264 | 17,494 (0%) | 0% | 84.6 | 783,920 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.87 per share. | 07 Jan 2026 | 9,264 | 26,758 (0%) | 0% | 52.9 | 489,788 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 3,829 | 9,254 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Sale of securities on an exchange or to another person at price $ 84.62 per share. | 07 Jan 2026 | 3,829 | 17,494 (0%) | 0% | 84.6 | 324,010 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.58 per share. | 07 Jan 2026 | 3,829 | 21,323 (0%) | 0% | 37.6 | 143,894 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 3,460 | 7,879 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Sale of securities on an exchange or to another person at price $ 84.62 per share. | 07 Jan 2026 | 3,460 | 17,494 (0%) | 0% | 84.6 | 292,785 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.60 per share. | 07 Jan 2026 | 3,460 | 20,954 (0%) | 0% | 32.6 | 112,796 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2026 | 2,101 | 11,339 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Sale of securities on an exchange or to another person at price $ 85.36 per share. | 07 Jan 2026 | 2,101 | 17,494 (0%) | 0% | 85.4 | 179,341 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.60 per share. | 07 Jan 2026 | 2,101 | 19,595 (0%) | 0% | 32.6 | 68,493 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 19,350 | 19,350 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Sale of securities on an exchange or to another person at price $ 80.91 per share. | 25 Nov 2025 | 16,777 | 17,494 (0%) | 0% | 80.9 | 1,357,442 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.77 per share. | 25 Nov 2025 | 16,777 | 34,271 (0%) | 0% | 53.8 | 902,099 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2025 | 16,777 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.51 per share. | 15 Oct 2025 | 6,000 | 21,937 (0%) | 0% | 48.5 | 291,060 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 6,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Sale of securities on an exchange or to another person at price $ 72.94 per share. | 15 Oct 2025 | 6,000 | 15,937 (0%) | 0% | 72.9 | 437,654 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 2,820 | 60,406 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 2,820 | 18,757 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Sale of securities on an exchange or to another person at price $ 73.62 per share. | 15 Oct 2025 | 1,263 | 17,494 (0%) | 0% | 73.6 | 92,984 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Sale of securities on an exchange or to another person at price $ 61.02 per share. | 03 Sep 2025 | 3,162 | 15,009 (0%) | 0% | 61.0 | 192,943 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2025 | 2,234 | 13,083 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.58 per share. | 03 Sep 2025 | 2,234 | 18,171 (0%) | 0% | 37.6 | 83,954 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2025 | 928 | 13,440 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.60 per share. | 03 Sep 2025 | 928 | 15,937 (0%) | 0% | 32.6 | 30,253 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 33,000 | 75,521 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 22,000 | 22,000 | - | - | Performance Restricted Stock Units | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 12,295 | 63,226 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 12,295 | 20,204 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Sale of securities on an exchange or to another person at price $ 32.78 per share. | 15 Jan 2025 | 4,267 | 15,937 (0%) | 0% | 32.8 | 139,855 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 22,000 | 22,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | 15 Oct 2024 | 11,280 | 42,521 | - | - | Restricted Stock Unit | ||
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resourses Ofc | 29 Sep 2024 | 15,040 | 15,040 | - | - | Non-Qualified Stock Option (right to buy) |